Avoidance Patterns
A careful clinical evaluation provides insight and clarity on avoidance patterns. Diagnosis and treatment depend on a thorough understanding of your history, biology, and environment. We emphasize an evidence-based approach to finding sustainable relief.
Overview
Avoidance provides immediate, reliable relief from anxiety, but it reinforces the belief that a situation was genuinely dangerous, strengthening fear over time via negative reinforcement. This transdiagnostic mechanism maintains Panic Disorder, Social Anxiety, OCD, PTSD, and others.
How it's diagnosed
Avoidance is examined as a component of multiple conditions rather than a standalone diagnosis. Evaluating involves identifying what is being avoided, tracking if avoidance has expanded, identifying covert safety behaviors, and mapping its functional impact on work, relationships, and health.
Non-medication strategies
Exposure therapy is the gold-standard treatment, resulting in fear extinction over time—teaching the brain's memory system that situations are safe. It involves gradual, consistent, repeated exposure without using safety behaviors. ACT-based values work helps motivate often uncomfortable change.
Medication strategies
There is no specific medication for avoidance behavior. Rather, medications (like SSRIs or SNRIs for GAD, Panic Disorder, or OCD) lower overall threat-sensitivity and baseline anxiety, thereby creating better conditions for exposure therapy to proceed.
Get clarity on your symptoms
Rebu is preparing to launch in New York. Connect with our team for availability updates and next steps.
Selected Sources & Clinical Disclaimer
These pages are educational only and are not a diagnosis, medical advice, or a substitute for a clinician’s evaluation. Diagnosis and treatment depend on history, symptom duration, impairment, safety risk, medical factors, medications, substances, and clinician judgment. If someone is in crisis, they should call 911, 988, or go to the nearest emergency room.
Information informed by guidelines and literature from:
• National Institute of Mental Health (NIMH)
• Anxiety & Depression Association of America (ADAA)
• Neuropsychopharmacology
• Current Psychiatry Reports